BioNxt Advances Semaglutide ODF Program into Active Pharmaceutical Development

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/8/2026

1. TTD
2. NET
3. ABNB
4. TEAM
5. FROG
6. DV
7. TWLO
8. CART
9. SPY
10. U

Go back to BioNxt Advances Semaglutide ODF Program into Active Pharmaceutical Development
(AMEX: BNXTF) Delayed: 0.22 -0.01 (4.35%)
Previous Close $0.23    52 Week High $ 
Open $0.22    52 Week Low $ 
Day High $0.22    P/E N/A 
Day Low $0.22    EPS $ 
Volume 130